Dan Hartman
Director/Board Member chez SPEXIS AG
Profil
Dan L.
Hartman is currently the Director of Integrated Development at the Bill & Melinda Gates Foundation Trust since 2012.
He is also currently the Director at Spexis Ltd.
since 2021.
Additionally, he holds the position of Director at EnBiotix, Inc. since 2012 and is a member of the Scientific and Medical Advisory Board at Hopen Life Sciences LLC.
Previously, Dr. Hartman served as the President & Chief Executive Officer at Great Lakes Drug Development, Inc. He also worked as an Executive Director & Principal at Pfizer Inc. Furthermore, he held the position of Principal at Eli Lilly & Co. from 1995 to 1999.
From 2000 to 2002, he served as the Vice President of Worldwide Clinical Development at Esperion Therapeutics, Inc. He was also the Senior Vice President of Product Development at deCODE genetics, Inc. In addition, he served as the Chief Medical Resident at Indiana University and was the President of The American Society for Clinical Pharmacology & Therapeutics.
From 2016 to 2019, he was a member of the National Center for Advancing Translational Sciences.
Dr. Hartman obtained a doctorate degree from Wayne State University (Michigan) and an undergraduate degree from Calvin University.
Postes actifs de Dan Hartman
| Sociétés | Poste | Début |
|---|---|---|
| SPEXIS AG | Director/Board Member | 30/12/2021 |
Bill & Melinda Gates Foundation Trust
 Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Corporate Officer/Principal | 01/01/2012 |
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Director/Board Member | - |
Hopen Life Sciences LLC
 Hopen Life Sciences LLC Investment ManagersFinance Hopen Life Sciences LLC(Hopen Life Sciences) is a venture capital firm founded in 2006 by Mark P. Olesnavage and Jerry Callahan. The firm is headquartered in Grand Rapids, Michigan. | Consultant / Advisor | - |
Anciens postes connus de Dan Hartman
| Sociétés | Poste | Fin |
|---|---|---|
National Center for Advancing Translational Sciences
 National Center for Advancing Translational Sciences National AgencyGovernment National Center for Advancing Translational Sciences studies translation on a system-wide level as a scientific and operational problem. The company was founded in 2012 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 01/01/2019 |
| ESPERION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2001 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 31/12/1999 |
| Indiana University | Corporate Officer/Principal | - |
The American Society for Clinical Pharmacology & Therapeutics
 The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | President | - |
Formation de Dan Hartman
| Wayne State University (Michigan) | Doctorate Degree |
| Calvin University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| SPEXIS AG | Health Technology |
| Entreprise privées | 7 |
|---|---|
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
Bill & Melinda Gates Foundation Trust
Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Finance |
The American Society for Clinical Pharmacology & Therapeutics
The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Commercial Services |
Hopen Life Sciences LLC
Hopen Life Sciences LLC Investment ManagersFinance Hopen Life Sciences LLC(Hopen Life Sciences) is a venture capital firm founded in 2006 by Mark P. Olesnavage and Jerry Callahan. The firm is headquartered in Grand Rapids, Michigan. | Finance |
Great Lakes Drug Development, Inc.
 Great Lakes Drug Development, Inc. Packaged SoftwareTechnology Services Part of Certara, Inc., Great Lakes Drug Development, Inc. is a private company that develops software applications for drug development consultancy services. The company is based in Brighton, MI. Great Lakes Drug Development was acquired by Certara USA, Inc. on August 13, 2013. | Technology Services |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National Center for Advancing Translational Sciences studies translation on a system-wide level as a scientific and operational problem. The company was founded in 2012 and is headquartered in Rockville, MD. | Government |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Health Services |
